Jeffrey A. Leerink is the CEO of SVB Securities. There, he is charged with defining, leading and executing the firm’s overarching business strategy and driving clarity, alignment and profitability across the entire business. Under Jeffrey’s leadership, the firm has grown to become a leading healthcare investment bank and company building partner.
Jeffrey founded Leerink Partners in 1995 and in 2019 merged the firm with SVB Financial Group, parent company to Silicon Valley Bank, to become SVB’s investment banking platform. The firm is focused on providing differentiated healthcare knowledge and equity capital markets, equity research and mergers and acquisitions expertise to help its clients define and achieve their strategic and capital markets objectives.
In 2008, Jeffrey co-founded and was a member of the board of directors of Humedica, Inc., a clinical intelligence company that was incubated at Leerink Partners. In 2013 the company was acquired by Optum, a subsidiary of UnitedHealth Group.
In addition to FogPharma, Jeffrey currently serves on the boards of PatientsLikeMe. Additionally, he is a board director and the former chairman of the board at Big Brothers Big Sisters of Eastern Massachusetts. He is a member of the Harvard Medical School Board of Fellows and a board member of Senior Connect Acquisition Corp. (Nasdaq: SNRH).
Jeffrey holds a B.A. in economics from Union College.